25-Hydroxyvitamin D Assay Variations and Impact on Clinical Decision Making
- 1 March 2012
- journal article
- Published by The Endocrine Society in Journal of Clinical Endocrinology & Metabolism
- Vol. 97 (3), 835-843
- https://doi.org/10.1210/jc.2011-2584
Abstract
Laboratories are increasingly shifting to new automated 25-hydroxyvitamin D (25-OHD) assays, with subsequent variability in results.Keywords
This publication has 27 references indexed in Scilit:
- Evaluation, Treatment, and Prevention of Vitamin D Deficiency: an Endocrine Society Clinical Practice GuidelineJournal of Clinical Endocrinology & Metabolism, 2011
- The 2011 Report on Dietary Reference Intakes for Calcium and Vitamin D from the Institute of Medicine: What Clinicians Need to KnowJournal of Clinical Endocrinology & Metabolism, 2011
- Hypovitaminosis D in developing countries—prevalence, risk factors and outcomesNature Reviews Endocrinology, 2010
- IOF position statement: vitamin D recommendations for older adultsOsteoporosis International, 2010
- Vitamin D DeficiencyNew England Journal of Medicine, 2007
- Hypovitaminosis D osteopathy: Is it mediated through PTH, lean mass, or is it a direct effect?Bone, 2006
- Which circulating level of 25-hydroxyvitamin D is appropriate?The Journal of Steroid Biochemistry and Molecular Biology, 2004
- Hypovitaminosis D in Healthy SchoolchildrenPublished by American Academy of Pediatrics (AAP) ,2001
- Hypovitaminosis D in a Sunny Country: Relation to Lifestyle and Bone MarkersJournal of Bone and Mineral Research, 2000
- Hypovitaminosis D in a Sunny CountryNew England Journal of Medicine, 1999